Company Filing History:
Years Active: 2004-2010
Title: Sohelia Korourian: Innovator in Minimally Invasive Breast Cancer Treatments
Introduction
Sohelia Korourian is a prominent inventor based in Little Rock, AR (US). He has made significant contributions to the field of medical technology, particularly in the diagnosis and treatment of breast cancer. With a total of 2 patents, his work focuses on developing minimally invasive methods that enhance patient outcomes.
Latest Patents
Korourian's latest patents include innovative techniques for breast cancer treatment. One of his notable inventions is a method for minimally invasive diagnosis and treatment for breast cancer. This invention provides a treatment method to excise a cancerous lesion, such as in the breast, with subsequent ablation of the margin. The method allows for location and excision with ablation under open guidance or guided imaging, and it facilitates diagnosis by cytology. It may also be a same-day method with diagnosis occurring before or immediately after excision. Additionally, he has developed a method for detecting and excising nonpalpable lesions. This novel approach involves hematoma-directed ultrasound guided excisional breast biopsy, which can be used to guide the excision of lesions visualized by various imaging techniques.
Career Highlights
Sohelia Korourian is affiliated with the University of Arkansas, where he continues to advance his research and innovations in medical technology. His work has the potential to transform the way breast cancer is diagnosed and treated, making procedures less invasive and more effective.
Collaborations
Korourian has collaborated with esteemed colleagues, including V Suzanne Klimberg and Steven E Harms, to further enhance the impact of his inventions in the medical field.
Conclusion
Sohelia Korourian's contributions to minimally invasive breast cancer treatments exemplify the importance of innovation in healthcare. His patents reflect a commitment to improving patient care through advanced medical techniques.